Antimuscarinics for treatment of overactive bladder (Q35615145)

9 August 2017

1 reference

title

Antimuscarinics for treatment of overactive bladder (English)

1 reference

9 August 2017

Karl-Erik Andersson

1

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

3

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

46-53

1 reference

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Prevalence and burden of overactive bladder in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Epidemiology, pathophysiology, and evaluation of urinary incontinence and overactive bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Estimated economic costs of overactive bladder in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Antimuscarinics and the overactive detrusor--which is the main mechanism of action?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

M2 signaling in smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Muscarinic inhibition of ATP-sensitive K+ channels by protein kinase C in urinary bladder smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Therapeutic opportunities from muscarinic receptor research

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Which muscarinic receptor is important in the bladder?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

M(3) muscarinic receptors mediate contraction of human urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Gender comparison of muscarinic receptor expression and function in rat and human urinary bladder: differential regulation of M2 and M3 receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Evidence for inhibitory nicotinic and facilitatory muscarinic receptors in cholinergic nerve terminals of the rat urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Prejunctional facilitatory and inhibitory modulation of parasympathetic nerve transmission in the rabbit urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Prejunctional muscarinic receptors modulating acetylcholine release in rabbit detrusor smooth muscles

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Function, signal transduction mechanisms and plasticity of presynaptic muscarinic receptors in the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Bladder activation: afferent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

The Effect of Ubretid on Bladder Function after Recent Complete Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Uninhibited Neurogenic Bladder Treated with Prazosin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Evidence that M3 muscarinic receptors in rat parotid gland couple to two second messenger systems

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Muscarinic cholinergic receptor subtypes in rat sublingual glands

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Both M1 and M3 receptors regulate exocrine secretion by mucous acini

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Muscarinic receptors in the mammalian heart

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Muscarinic regulation of cardiac ion channels

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Potential role of muscarinic agonists in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Acetylcholine, aging, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Alzheimer's disease: relationship between muscarinic cholinergic receptors, beta-amyloid and tau proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Muscarinic receptors and gastrointestinal tract smooth muscle function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Current concepts in the treatment of disorders of micturition

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Trospium chloride: an effective option for medical treatment of bladder overactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Tolterodine--a new bladder-selective antimuscarinic agent

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Tolterodine--a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Urodynamic and other effects of tolterodine: a novel antimuscarinic drug for the treatment of detrusor overactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

1 reference

7 January 2021

Muscarinic receptor antagonists in the treatment of overactive bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Tolterodine: a review of its use in the treatment of overactive bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Oxybutynin and the overactive bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

The pharmacokinetics of oxybutynin in man

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Inhibitory effects of propiverine on rat and guinea-pig urinary bladder muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Discovery & development of selective M3 antagonists for clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Influence of behavior modification on overactive bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900622-7

7 January 2021

10.1016/S1474-4422(03)00622-7

Identifiers

DOI

1 reference

9 August 2017

1 reference